ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$2.00
-0.12 (-5.66%)
As of Mar 29, 10:34 PM ET ·
Financial Highlights (FY 2025)
Revenue
90.95M
Net Income
6.08M
Gross Margin
64.5%
Profit Margin
6.7%
Rev Growth
-3.1%
D/E Ratio
0.48
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 64.5%
Operating Margin 8.6% 8.6% 8.1%
Profit Margin 6.7% 9.4% 7.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 90.95M 87.33M 87.17M
Gross Profit 58.69M 56.35M 56.25M
Operating Income 7.80M 7.53M 7.07M
Net Income 6.08M 8.20M 6.12M
Gross Margin 64.5% 64.5% 64.5%
Operating Margin 8.6% 8.6% 8.1%
Profit Margin 6.7% 9.4% 7.0%
Rev Growth -3.1% +6.5% -4.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 31.50M 37.32M 37.66M
Total Equity 65.25M 74.11M 65.78M
D/E Ratio 0.48 0.50 0.57
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 10.53M 10.19M 12.10M
Free Cash Flow 5.16M 6.96M 5.08M